Bank Pictet & Cie (Europe) AG - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 16 filers reported holding IMMUNE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank Pictet & Cie (Europe) AG ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$15,000
-40.0%
12,9000.0%0.00%
-88.0%
Q2 2015$25,000
+8.7%
12,9000.0%0.02%
+316.7%
Q1 2015$23,000
-8.0%
12,9000.0%0.01%0.0%
Q4 2014$25,000
-44.4%
12,9000.0%0.01%
-50.0%
Q3 2014$45,00012,9000.01%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Geduld E E 25,000$7,0000.01%
TWO SIGMA SECURITIES, LLC 31,509$9,0000.00%
Ifrah Financial Services, Inc. 13,000$4,0000.00%
Virtu KCG Holdings LLC 151,047$43,0000.00%
UBS Group AG 63,449$18,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 2,000$00.00%
BANK OF AMERICA CORP /DE/ 31$00.00%
GEODE CAPITAL MANAGEMENT, LLC 242,723$67,0000.00%
DEUTSCHE BANK AG\ 28$00.00%
GOLDMAN SACHS GROUP INC 156,868$44,0000.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders